Go Pro
NASDAQ:PPH

VanEck Pharmaceutical ETF (PPH) Price, Holdings, & News

VanEck Pharmaceutical ETF logo
$108.06 -0.08 (-0.07%)
Closing price 04:00 PM Eastern
Extended Trading
$108.29 +0.23 (+0.21%)
As of 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About VanEck Pharmaceutical ETF (NASDAQ:PPH)

Advanced

Key Stats

Today's Range
$107.29
▼
$108.33
50-Day Range
$108.14
▼
$117.87
52-Week Range
$90.60
▼
$118.00
Volume
272,518 shs
Average Volume
310,517 shs
Market Capitalization
$1.01 billion
Assets Under Management
$1.03 billion
Dividend Yield
2.01%
Net Expense Ratio
0.36%
Aggregate Rating
Moderate Buy

ETF Overview

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

VanEck Pharmaceutical ETF Expenses

TypePPHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.35%0.55%0.57%0.54%0.53%
Other Expenses0.01%0.52%0.53%0.38%0.54%
Total Expense0.36%0.76%0.75%0.69%0.73%
Fee Waiver0.00%-0.85%-0.67%-0.41%-0.68%
Net Expense0.36%0.58%0.63%0.61%0.60%
Receive PPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PPH ETF News Headlines

(PPH) VanEck Pharmaceutical ETF
First Look: Elon’s “Starphone”
Rumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.tc pixel
See More Headlines

PPH ETF - Frequently Asked Questions

VanEck Pharmaceutical ETF's stock was trading at $103.17 on January 1st, 2026. Since then, PPH shares have increased by 4.7% and is now trading at $108.06.

Shares of PPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Pharmaceutical ETF investors own include Waste Connections (WCN), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), DiamondRock Hospitality (DRH), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Fund Details

Issuer
Van Eck
Fund Name
VanEck Pharmaceutical ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:PPH
Inception Date
12/20/2011
Fund Manager
Hao-Hung Peter Liao, Guo Hua Jason Jin
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
MVIS US Listed Pharmaceutical 25 Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
Global
Number of Holdings
26

Fund Statistics

Assets Under Management
$1.03 billion
Average Daily Volume
$282.07 thousand
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
Van Eck Associates Corporation
Advisor
Van Eck Associates Corporation
Custodian
State Street Bank and Trust Company
Distributor
Van Eck Securities Corporation
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
IMC

Options

Optionable
Optionable
Options Volume
11
Put Options
6
Call Options
5
Short Interest
2,467,111 shs

Miscellaneous

Beta
0.46
Creation Unit
50,000
Creation Fee
$500.00
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Top 10 PPH Holdings

PPH Sector Exposure

PPH Industry Exposure


This page (NASDAQ:PPH) was last updated on 10/2/2026 by MarketBeat.com Staff.
From Our Partners